Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ("Telo" or the "Company"), a leader in diagnostic and prognostic innovation through its proprietary multi-factor telomere analytics, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback